Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF
  • Written by Admin
  • Written date 2019-01-14 11:38:28
  • Inquire 7297
PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended
and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF at KDDF R&D workshop 2018 (September 6-7) at Sun Valley Hotel in Yeoju, KOREA.

List





Prev Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa
Next Quarterly Magazine KoNECT 14호(2018.12)_Interview of Dr. Jin-San Yoo